SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade
Search This Board:
Last Post: 5/29/2015 1:45:37 PM - Followers: 303 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 05/26/2015 08:05:00 AM
ONVO News: How Organovo Holdings Inc. Printed Profits in April 05/08/2015 09:18:02 AM
ONVO News: L'Oreal USA Announces Research Partnership with Organovo to Develop 3-D Bioprinted Skin Tissue 05/05/2015 11:05:00 AM
ONVO News: Watch Out Organovo! This "Most Innovative" 3D Bioprinting Startup Has You in its Crosshairs 04/29/2015 12:09:02 PM
ONVO News: Organovo Holdings's Buy Rating Reaffirmed at Cantor Fitzgerald (ONVO) 04/26/2015 03:53:19 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#8269   What are you seeing here that signals the RallyTheMarket 05/29/15 01:45:37 PM
#8268   Hey can you tell me what signals the RallyTheMarket 05/29/15 01:43:55 PM
#8267   One more NR and the squeeze is so CommonCents4Dollars 05/29/15 01:16:03 PM
#8266   squeeze in play here! give us some fluff Rdhoughton 05/29/15 01:06:06 PM
#8264   5,49$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ muggel 05/29/15 09:52:35 AM
#8263 muggel 05/29/15 09:48:10 AM
#8262   Do we break 5 today? If so, what's bettyfordallstar 05/29/15 07:06:50 AM
#8261   Probably see covering @ $5.Good volume again. paulscary 05/28/15 03:55:18 PM
#8260   big handle on this cup dshade 05/28/15 02:16:03 PM
#8259   Latest short #'s are out. Slight increase as bettyfordallstar 05/28/15 09:01:39 AM
#8258   Interesting read. bettyfordallstar 05/28/15 02:18:50 AM
#8257   Good volume going into the close at (near) Alvie 05/27/15 10:21:13 PM
#8256   Possible short squeeze in the making. paulscary 05/27/15 07:18:35 PM
#8255   Procter&Gamble_Launches_3D_Bioprinting_Grant_Competition http://inside3dpri paulscary 05/27/15 06:44:13 PM
#8254   Adding to position. Or, suppose it's Time to Not_a_Doubt 05/27/15 03:15:57 PM
#8253   Organovo Holdings, Inc. (NYSE MKT: ONVO; " Organovo rumper 05/26/15 08:36:47 AM
#8252   Procter & Gamble has become the latest household bettyfordallstar 05/26/15 07:13:19 AM
#8251   bettyfordallstar 05/26/15 04:20:00 AM
#8250   Looks like P & G wants to get bettyfordallstar 05/25/15 10:10:11 PM
#8249   I don't see ONVO as a printer at hotrod34racer 05/25/15 10:29:05 AM
#8248   What's happened in the 3D printing stocks dragged rumper 05/25/15 06:43:41 AM
#8247   Should be an interesting next couple of weeks bettyfordallstar 05/22/15 08:47:40 PM
#8246   I Thought L'Oreal Was A Lipstick Company rumper 05/20/15 03:31:37 PM
#8245   Does anyone else besides me think that these RandolRocketman 05/20/15 02:46:28 PM
#8244   ditto. slow and steady. long and focused dshade 05/20/15 12:57:45 PM
#8243   I totally agree. chaostrader 05/20/15 12:32:59 PM
#8242   The L'Oreal Deal Could Be Bigger Than Expected rumper 05/19/15 06:28:30 PM
#8241   Hurdle as in gap over $5. May I'll chaostrader 05/19/15 05:58:06 PM
#8240   All the way to $5?! You mean a RallyTheMarket 05/19/15 05:51:12 PM
#8239   We're going to see ONVO hurdle $5 like chaostrader 05/19/15 04:54:53 PM
#8238   The L'oreal tie-up is hitting the news. RandolRocketman 05/19/15 12:54:52 PM
#8237 muggel 05/19/15 10:42:17 AM
#8236 muggel 05/19/15 10:28:19 AM
#8235   comes news ?????????!!!!!!!!!!!!!!!!! muggel 05/19/15 10:02:59 AM
#8234   HUGE ???????????????????????????????? muggel 05/19/15 09:58:42 AM
#8233   I agree there:) Bylerzone 05/18/15 03:59:37 PM
#8232   should see a pop soon jmo chaostrader 05/18/15 12:01:12 PM
#8231   Is this dead money for a while? Spudskie 05/15/15 01:34:17 PM
#8230   Top 5 Institution Share Holders rumper 05/15/15 04:26:57 AM
#8229   Fidelity shows Institutions holding 26.9% currently, or 29.2% Alvie 05/14/15 09:55:15 PM
#8228   We are at a critical support level and rayank 05/14/15 09:18:21 PM
#8227   Short Squeeze lining up - one more NR CommonCents4Dollars 05/14/15 08:59:00 PM
#8226   The model has two components to it. nsomniyak 05/14/15 12:01:14 AM
#8224   Only pointing out that this was an article Alvie 05/13/15 04:20:48 PM
#8222   What are you implying with your bold letters? RallyTheMarket 05/13/15 03:34:44 PM
#8221   "The author is not receiving compensation for it Alvie 05/12/15 03:45:27 PM
#8220   NYSEMKT:ONVO) saw its shares rally more than 28% Lestatk 05/12/15 02:56:18 PM
#8219   Only predictions are this will be a great dshade 05/12/15 12:39:41 PM
#8218   Looks more like the market has ignored ONVO. RallyTheMarket 05/12/15 12:36:03 PM
#8217   Again, pay attention. I did not type buying dshade 05/12/15 12:33:10 PM